Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- NeoCell Corporation Files for Patent Protection on Canine and Equine Collagen Joint Health Supplement
Company announces the filing of patent protection on ArthroPet(TM), made with kolla2®.
- Nutri Pharmaceuticals Research Inc. Reports First Quarter Earnings
Company reports sales of $421,000 as compared to $290,000 in first quarter of the prior year, with profit approximated at$339,000, compared to $207,000 in same period of the prior year.
- Nutri Pharmaceuticals Research Inc. Reports First Quarter Earnings
Company reports sales of $421,000 as compared to $290,000 in first quarter of the prior year, with profit approximated at$339,000, compared to $207,000 in same period of the prior year.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- Neptune Technologies & Bioressources Inc. Appoints V.P. Sales & Marketing
Mr. Donald Allard has joined Neptune as the Vice President, Sales and Marketing, to be involved in all aspects of the sales process and marketing, including business development, branding, customer relations, and promotion.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- DENOMEGA NUTRITIONAL OILS; New name for Denofa Nutritional Oils
Denofa Nutritional Oils, a former division of Denofa, is changing its name to Denomega Nutritional Oils.
- KGK Synergize Inc., Seeks Private Placement for Growth; JANUS CORPORATE FINANCE Retained as Principal Advisor
Company has retained Janus Corporate Finance to act as principal financial advisor in arranging additional growth capital for its emerging nutraceutical product technologies.
- KGK Synergize Inc., Seeks Private Placement for Growth; JANUS CORPORATE FINANCE Retained as Principal Advisor
Company has retained Janus Corporate Finance to act as principal financial advisor in arranging additional growth capital for its emerging nutraceutical product technologies.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Paul Intlekofer Elected CEO of Nutrition 21
Company's Board of Directors has elected Paul Intlekofer as president and chief executive officer.
- Neptune Technologies & Bioressources Inc. Reports Third Quarter Results
Company reports revenues of $1,822,000 compared to $1,292,000 for the prior year, with a net profit of $1,038,000 or $0.032 per share for the quarter.
- Neptune Technologies & Bioressources Inc. Reports Third Quarter Results
Company reports revenues of $1,822,000 compared to $1,292,000 for the prior year, with a net profit of $1,038,000 or $0.032 per share for the quarter.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EuroPharma Now Offering Products Utilizing New Patented Coating Technology For Specific Uses
Company is partnering with a European company to bring a new proprietary and patented enteric coating technology, which preserves active ingredients, to US companies for tablet applications.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- EcoNugenics® Granted New U.S. Patent for Modified Pectin and Alginates
United States Patent and Trademark Office (USPTO) has issued the company US Patent No. 7,026,302.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 second quarter were $41.0 million compared to $38.8 million prior year, with net income of $5.0 million, or $0.43 diluted earnings per share, compared to $3.5 million, or $0.29 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 second quarter were $41.0 million compared to $38.8 million prior year, with net income of $5.0 million, or $0.43 diluted earnings per share, compared to $3.5 million, or $0.29 diluted earnings per share, for the same quarter of fiscal 2005.
- NBTY Reports Second Quarter Results
Company reports net sales of $482 million compared to net sales of $443 million prior year, with $39 million increase including $32 million in net sales from NBTY's recent acquisitions: $26 million from Solgar, $3 million from LeNaturiste and $3 million from SISU. Net income was $21 million, or $0.31 per diluted share, compared to $21 million, or $0.30 per diluted share, for the fiscal second quarter ended March 31, 2005.
- NBTY Reports Second Quarter Results
Company reports net sales of $482 million compared to net sales of $443 million prior year, with $39 million increase including $32 million in net sales from NBTY's recent acquisitions: $26 million from Solgar, $3 million from LeNaturiste and $3 million from SISU. Net income was $21 million, or $0.31 per diluted share, compared to $21 million, or $0.30 per diluted share, for the fiscal second quarter ended March 31, 2005.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Phosphagenics & Nestle Nutrition Sign Agreement for Development of Phospha E(R) for Foods and Beverages
Phosphagenics Limited and Nestle Nutrition, a unit of Nestle S.A. have entered into a research agreement to develop Phosphagenics' Phospha E(R) for use in Nestle Nutrition's products.
- Natural Alternatives International, Inc. Announces Third Quarter Results
Company reports net income of $621,000 or $0.09 per diluted share compared to $277,000 or $0.04 per diluted share for the comparable quarter prior year, as net saloes increase from $22.5 million to $23.3 million, including net sales from recent acquisition Real Health Laboratories of $2.7 million for the quarter.
- Natural Alternatives International, Inc. Announces Third Quarter Results
Company reports net income of $621,000 or $0.09 per diluted share compared to $277,000 or $0.04 per diluted share for the comparable quarter prior year, as net saloes increase from $22.5 million to $23.3 million, including net sales from recent acquisition Real Health Laboratories of $2.7 million for the quarter.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Indena Signs Long-Term Agreement With Alliance Principle Ingredients As Its Canadian Distributor
Indena has named Alliance Principle Ingredients as its Canadian distributor for its line of herbal & plant extracts for use in dietary supplements and food products.
- Nu Skin Enterprises Reports First-Quarter 2006 Results
Company reports revenue of $265.8 million and a loss per share of $0.18 with net loss of $12.8 million and $0.18, compared to net income of $17.7 million and earnings per share of $0.25 during the first quarter of 2005.
- Nu Skin Enterprises Reports First-Quarter 2006 Results
Company reports revenue of $265.8 million and a loss per share of $0.18 with net loss of $12.8 million and $0.18, compared to net income of $17.7 million and earnings per share of $0.25 during the first quarter of 2005.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- Nu Skin Enterprises Announces New Corporate Organization and Appoints Executives to Key Positions
Dan Chard, former head of the company's European operations, has been appointed to the position of executive vice president, distributor success, Dr. Joe Chang, former president of the Pharmanex division, has been appointed to serve as the company's chief scientific officer and executive vice president, product development, Lori Bush, former president of the company's Nu Skin division, will be engaged as a consultant and has been appointed to serve as chairwoman of the Nu Skin Scientific Advisory Board.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- The Hain Celestial Group Announces Third Quarter Sales and Earnings
Company reports sales of $196.4 million in its third quarter, compared to prior year's $161.3 million, with net income of $9.7 million, versus the prior year's $7.7 million.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- SunOpta Announces First Quarter Results
Company reports revenues of $133,312,000 as compared to $86,223,000 in the first quarter of the prior year, led by a 52.5% increase in revenues within the Company's vertically integrated natural and organic food operations, with net income of $3,012,000 or $0.053 per diluted common share as compared to $6,605,000 or $0.116 per diluted common share in the prior year.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Ocean Spray’s Rob Beams Appointed Vice President
Ocean Spray, has announced the appointment of Rob Beams to the position of Vice President, Agricultural Supply Development.
- Sunwin International Neutraceuticals Forms a Canadian Subsidiary to Distribute Chinese Herb-Based Medicines
Company has formed a wholly owned subsidiary in Canada, Sunwin (Canada) Pharmaceuticals, Limited, in order to market its Chinese herb-based medicines, including Hypericin, Honeysuckle, Angelica, Chrysanthemum, Epimedium, and Dandelion, throughout Canada
- Sunwin International Neutraceuticals Forms a Canadian Subsidiary to Distribute Chinese Herb-Based Medicines
Company has formed a wholly owned subsidiary in Canada, Sunwin (Canada) Pharmaceuticals, Limited, in order to market its Chinese herb-based medicines, including Hypericin, Honeysuckle, Angelica, Chrysanthemum, Epimedium, and Dandelion, throughout Canada
- Herbalife Ltd. Announces First-Quarter Results
Company reports net sales of $455.8 million with net income of $38.7 million, or $0.53 per diluted share, compared to $13.3 million, or $0.19 per diluted share in 2005.
- Herbalife Ltd. Announces First-Quarter Results
Company reports net sales of $455.8 million with net income of $38.7 million, or $0.53 per diluted share, compared to $13.3 million, or $0.19 per diluted share in 2005.
- GNC Corporation Reports First Quarter 2006 Financial Results
Company reports EBITDA of $37.5 million compared to $27.9 million in the first quarter of 2005, as net income for the first quarter of 2006 increased to $11.4 million compared to $2.7 million in the first quarter of 2005.
- GNC Corporation Reports First Quarter 2006 Financial Results
Company reports EBITDA of $37.5 million compared to $27.9 million in the first quarter of 2005, as net income for the first quarter of 2006 increased to $11.4 million compared to $2.7 million in the first quarter of 2005.
- Wild Oats Markets, Inc. Reports First Quarter 2006 Results
Company reports net sales of $298.4 million, compared to $278.1 million in the first quarter of 2005, with net income of $2.9 million, or $0.10 per share, compared to a net loss of $1.2 million or $0.04 per share in last year's first quarter.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
|
QUEBEC CITY, QUEBEC -- (MARKET WIRE) -- 04/27/2006 -- Advitech Inc. (TSX VENTURE:AVI) today announced that it has reached an agreement in principle, setting forth the proposed scope of a marketing and distribution agreement for Dermylex™ with Enbio-Life Biotechnology & Medical Company Ltd, ("Enbio-Life"), a subsidiary of Yusheng Pharma. Enbio-Life is a Taiwanese company, which markets nutraceutical products in Taiwan, China and other Asian countries. This agreement is for the Taiwanese market and Enbio-Life has an option for the market in China as well.
Enbio-Life has agreed to pay an undisclosed payment in May 2006 to secure the negotiation exclusivity and to finalize a definitive marketing and distribution contract, to be entered into between the parties no later than August 31, 2006. Enbio-Life has already agreed to the Minimum Purchase Requirements for 2006 and 2007. The Contract will give Enbio-Life the exclusive rights from Advitech to market in Taiwan products using Dermylex™, Advitech's clinically-proven bioactive ingredient for the treatment of psoriasis. This three-year Contract will provide for Minimum Purchase Requirements to be met by Enbio-Life and royalties on sales generated by Enbio-Life to be paid to Advitech. Other terms and conditions of the Agreement were not disclosed.
Commenting on the news, Mr Renaud Beauchesne, CEO of Advitech, said: "We are very pleased with this Agreement because it provides Advitech with its first partnership in Asia and the possibility of entering new Asian markets in the near future. New market reports on psoriasis are showing an increasing incidence of the disease in these countries". Mr Jones Wang, CEO of Enbio-Life, added ''We are seeking to build on this partnership with Advitech and, as we work directly with hospitals and clinics, we are confident that we shall create the demand and the right network for Dermylex™.''
About Enbio-Life Biotechnology and Medical Company Ltd.
EnBio-Life Biotechnology & Medical Company, Ltd. is a spin-off of YUSHENG PHARMACEUTICAL CO., LTD. Yusheng Pharma has been headed up by President Chen Jen Quei for over 40 years, and Enbio-Life has been created to focus on the development of chronic diseases and preventive medicine by marketing unique medical and nutraceutical products. Mr Jones Wang is the CEO of Enbio-Life that has offices in Taichung (Taiwan) and Shanghai (China).
About Dermylex™
Dermylex™ is Advitech's orally administered product for mild to moderate plaque psoriasis. Dermylex™ is made from Advitech's XP-828L, a bioactive ingredient with proven clinical efficacy. On July 5, 2005, the Company reported positive results from its Phase II clinical trial of XP-828L for treating mild to moderate psoriasis. The 112-day, multi-center, double blind, placebo-controlled study, involving 84 patients, confirmed the efficacy and excellent safety profile of XP-828L for treating mild to moderate psoriasis.
About Advitech
Advitech is a life science and technology company specializing in the development of clinically tested bioactive ingredients for chronic immune-mediated inflammatory diseases (IMID), such as psoriasis and inflammatory bowel diseases. Advitech's common shares are listed on the TSX Venture Exchange under the symbol AVI. The number of common shares outstanding is 54,799,818.
This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
|